Phase3 Parkinson Studie "floppt"
www.fiercebiotech.com/biotech/...on-s-test-against-merck-drug
|
Phase3 Parkinson Studie "floppt"
www.fiercebiotech.com/biotech/...on-s-test-against-merck-drug
Zahlen für Q3/19
ir.intecpharma.com/news-releases/...019-financial-results-and
6,5 Mio. $ Offering
ir.intecpharma.com/news-releases/...5-million-public-offering
Zahlen für Q2/20
Mit ATM Offering versucht sich das Unternehmen über Wasser zu halten.
"In May 2020, the Company raised $5.0 million in a registered direct offering of 16,291,952 ordinary shares at a purchase price of $0.3069 per share."
ir.intecpharma.com/news-releases/...020-financial-results-and
Wertung | Antworten | Thema | Verfasser | letzter Verfasser | letzter Beitrag | |
8 | NTEC 0,49$ (-84%) | Vassago | Vassago | 06.08.20 16:22 |